Raymond James Financial Services Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$392K Sell
3,301
-447
-12% -$41.1K ﹤0.01% 2780
2024
Q2
$301K Sell
3,748
-1,672
-31% -$153K ﹤0.01% 2867
2024
Q1
$500K Sell
5,420
-1,191
-18% -$114K ﹤0.01% 2507
2023
Q4
$698K Buy
6,611
+1,411
+27% +$142K ﹤0.01% 2198
2023
Q3
$565K Sell
5,200
-7,160
-58% -$792K ﹤0.01% 2251
2023
Q2
$1.33M Sell
12,360
-1,404
-10% -$158K ﹤0.01% 1765
2023
Q1
$1.71M Sell
13,764
-1,174
-8% -$161K ﹤0.01% 1576
2022
Q4
$2.24M Buy
14,938
+1,660
+13% +$255K ﹤0.01% 1375
2022
Q3
$1.79M Buy
13,278
+2,297
+21% +$351K ﹤0.01% 1478
2022
Q2
$1.64M Buy
10,981
+6,183
+129% +$945K ﹤0.01% 1553
2022
Q1
$818K Sell
4,798
-1,050
-18% -$176K ﹤0.01% 2080
2021
Q4
$1.51M Sell
5,848
-3,261
-36% -$893K ﹤0.01% 1714
2021
Q3
$2.49M Buy
9,109
+3,188
+54% +$1.01M 0.01% 1360
2021
Q2
$1.33M Sell
5,921
-3,421
-37% -$645K ﹤0.01% 1749
2021
Q1
$1.02M Sell
9,342
-300
-3% -$31.9K ﹤0.01% 1852
2020
Q4
$786K Sell
9,642
-2,201
-19% -$216K ﹤0.01% 1859
2020
Q3
$820K Buy
11,843
+2,226
+23% +$160K ﹤0.01% 1669
2020
Q2
$642K Buy
+9,617
New +$480K ﹤0.01% 1754

Other funds holding BNTX

Raymond James Financial Services Advisors's BNTX Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its BioNTech (BNTX) stake by 12% in Q3 2024, selling an estimated $41.1K and leaving 3,301 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #2780.

Raymond James Financial Services Advisors first reported a position in BNTX in Q2 2020 and has held it in 18 quarters since. The position peaked at $2.49M in Q3 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Raymond James Financial Services Advisors held 3,301 shares of BioNTech worth $392K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 447 BioNTech shares in Q3 2024, an estimated $41.1K.
  • BioNTech made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2780 holding.
  • Raymond James Financial Services Advisors first reported a position in BioNTech in Q2 2020 and has held it in 18 quarters since.
  • Raymond James Financial Services Advisors's BioNTech position peaked at $2.49M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.